Hair Growth Treatment
Boston based hair growth company Follica has announced positive data from its ongoing safety and optimization study and is prepared to move into a pivotal FDA study later this year. Upon checking my email this morning I found a message from a top level executive at Follica pointing me to a press release sent out…
A new company with an interesting pipeline aimed at hair growth technology, Applied Biology, has recently surfaced on the internet. Background Applied Biology is a biotechnology company based in Irvine, California and led by dermatologist Dr. Andy Goren. The company’s About page gives a good description of Applied Biology’s focus: “Applied Biology is a biotechnology…
After initiating a rousing new trial for female hair loss last year, Histogen has been back on many people’s radar again. A video of Histogen’s recent presentation in New York City has been uploaded online and it contains some interesting items from the company. New CEO One news item coming from Histogen earlier this year…
Back in August 2017, UCLA researchers made headlines by discovering a new way to activate hair follicle stem cells. This was done through a metabolite called lactate. William Lowry and Heather Christofk of UCLA’s Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research were responsible for the lactate discovery. Lowry and Christofk…
Yesterday, Replicel released a May 2019 Update which mentioned a new study using its dermal injector device to treat hair loss. The end of the press release states: “Over the next 18 months you should expect to see: new clinical data from a study completed showing the value of the dermal injector in treating hair…
On April 24th-27th 2019 the 11th World Congress for Hair Research took place in Sitges, Barcelona. Usually, major announcements regarding the release of new treatments are not made at such conferences, however, worthwhile scientific information is typically shared. Importantly, companies who attend the WCHR are sometimes able to create business development opportunities. Below are some…
Puretech Health, the parent company of Follica, has recently issued a 2018 Annual Report to shareholders which contains news about its long-standing hair growth company. New Proprietary Compounds Among the important Follica news shared in the Puretech Annual Report is the mentioning of “next-generation proprietary compounds.” Yes, that compounds with an “s”, as in more…
Today, Cassiopea SpA has announced topline data from its fully completed phase 2 dose ranging trial for men with androgenic alopecia. The results of the trial were favorable. Phase 2 Trial for Clascoterone The trial which was completed by Cassiopea included 400 men and 4 different doses of clascoterone, also known as breezula, for the…
A new therapy targeting the PRL receptor to treat male and female pattern hair loss is being developed by a Chinese biopharmaceutical compay and Bayer AG. A press release was sent out April 7, 2019 by Hope Medicine Inc. detailing a newly signed licensing agreement with Bayer AG for the development of treatments for hair…
On February 4, 2019 Follicum announced via press release they have completed a preclinical trial using a new cream-like topical formulation of their peptide FOL-005. In the trial, Follicum measured the effects of their topical FOL-005 against industry standard hair-growth drug minoxidil. The trial was done on mice and took about four weeks to complete.…